Advancing imaging in clinical trials.


The Pharma Imaging Network for Therapeutics and Diagnostics is an international forum of professionals who meet monthly to evaluate, discuss, and recommend methods and strategies for imaging in clinical trials.

What We Do

Square outline icon

Convene the Field

In our meetings, we work through the methodological questions that shape imaging endpoints: from response criteria to reader performance to regulatory expectation.


Circle target outline icon

Build Shared Standards

Our members help shape practical approaches, shared frameworks, and recommendations that strengthen consistency and quality across imaging clinical trials.


Triangle outline icon

Speak with One Voice

Together we can influence how the field develops by engaging regulators, professional bodies, and industry as a recognized constituency.



Our members include imaging scientists and clinicians from pharmaceutical, biotechnology, and medical device companies; professionals from contract research organizations and central imaging laboratories; academics, radiologists, nuclear medicine physicians, statisticians, and consultants.

If your work touches clinical trials that use imaging to inform therapeutic, diagnostic, or safety endpoints, you belong here.

Who We Are


Next Meeting

Wednesday, October 28

11:00–12:00 ET

Discover Past Meetings

Join the Network

Membership is free and open to professionals working in or adjacent to clinical trials.